Heather Bassett, M.D., Chief Medical Officer, XSOLISToday’s relationship between payers and providers is more fraught than ever. With a history of transactional, often adversarial, fee-for-service contract negotiations, it’s no wonder that the healthcare industry…
Continue Reading
What You Should Know:– Aledade today announced the acquisition of Curia, a leader in value-based care analytics using practical applications of artificial intelligence (AI) to optimize the targeting of patient care and engagement programs….
Continue Reading
What You Should Know:– Ascensia Diabetes Care, a global diabetes care company announces a landmark global collaboration with SNAQ, an award-winning app-based solution that offers key insights on food and nutrition for people with diabetes (PWDs).–…
Continue Reading
Ashish Kachru, CEO, DataLinkThe new healthcare realm of value-based care (VBC), designed to reward healthcare providers with incentive payments for the quality of care and patient outcomes not simply the volume of services provided,…
Continue Reading
What You Should Know:– Nebraska-based Bluestem Health today announced it has launched an AI-based virtual medical assistant powered by Mediktor. This is available for both established and non-established patients to efficiently assess their symptoms…
Continue Reading
What You Should Know:– AGS Health, a provider for tech-enabled revenue cycle management (RCM) solutions announces the acquisition of the India-based patient access outsourcing business unit of the Florida-based healthcare technology company Availity.– With more…
Continue Reading
Tillmann Schwabe, General Manager of Everphone U.S.The Great Resignation changed how companies approach attracting and retaining talent. These days, it’s not enough to offer a competitive salary and traditional benefits like health insurance…
Continue Reading
Melissa Mooney, Director of eCOA Solutions Engineering at IQVIAIn the US alone, an estimated 1.9 million new cases of cancer were diagnosed in 2022, positioning oncology as a key subject of clinical research. Throughout oncology trial development, it is important that stakeholders acknowledge that only patients can fully understand the impact of treatment on their lives. Regulators are now looking beyond clinical indications such as tumor size and delayed disease progression. When evaluating the risks and benefits of treatment, they want to know whether the side effects are tolerable for patients and how these treatments could be improved from the patient’s…
Continue Reading
Sean Eaton, Senior Compliance Solutions Specialist at GHXAmerican health systems, hospitals and post-acute care providers are required to comply with hundreds of regulatory requirements. Facilitating this compliance comes with a high cost. According to the American Hospital Association, the average-sized community hospital spends nearly $7.6 million annually on administrative activities to support regulatory compliance. With the impending end of the COVID-19 public health emergency set to shake up healthcare regulations, ongoing healthcare labor shortages, and skyrocketing levels of clinician burnout, a perfect storm for non-compliance is brewing. Even with significant investments in administration to support compliance, overwhelmed providers can inadvertently leave gaps…
Continue Reading
Dr. Ty Vachon, CEO & Co-Founder at Oatmeal HealthToday, cancer is the second leading cause of death in the United States. Sadly, cancer disparities exist, with racial/ethnic minority, low-income, and uninsured populations suffering the greatest burden. That’s why routine cancer screening is critical to addressing cancer disparities as they have the potential to greatly reduce both incidence and mortality rates. To address this, Federally qualified health centers (FQHCs) are funded by the Health Resources and Services Administration to provide preventive and primary healthcare services, including cancer screening, to the nation’s most vulnerable populations We recently sat down with Oatmeal Health’s Co-Founder and…
Continue Reading
